The NPM1 mutations identified in approximately 20% of patients with AML [38] generate a novel mutant NPM1 protein with a mutant C-terminus that is recognized by HD T cells, and stimulation of HD T cells with epitopes derived from the mutant C-terminus of NPM1 incites strong T cell responses [6]. The gene discussed is NPM1; the disease is acute myeloid leukemia.